Stevens Capital Management’s Orthofix Medical OFIX Stock Holding History

Stevens Capital Management’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-9,038	Closed	-$427K	–	980
2017 Q3	$427K	Buy	+9,038	New	+$426K	0.02%	591
2017 Q2	–	Sell	-13,874	Closed	-$529K	–	1008
2017 Q1	$529K	Buy	13,874 +8,003	+136%	+$296K	0.02%	562
2016 Q4	$212K	Sell	5,871 -580	-9%	-$22K	0.01%	773
2016 Q3	$276K	Sell	6,451 -2,060	-24%	-$91.9K	0.01%	727
2016 Q2	$361K	Buy	8,511 +2,286	+37%	+$99.4K	0.01%	651
2016 Q1	$258K	Sell	6,225 -2,594	-29%	-$102K	0.01%	710
2015 Q4	$346K	Sell	8,819 -251	-3%	-$9.38K	0.01%	649
2015 Q3	$306K	Sell	9,070 -404	-4%	-$14.4K	0.01%	690
2015 Q2	$314K	Sell	9,474 -542	-5%	-$18.6K	0.01%	740
2015 Q1	$359K	Sell	10,016 -3,996	-29%	-$126K	0.01%	684
2014 Q4	$421K	Buy	14,012 +1,245	+10%	+$36.5K	0.01%	624
2014 Q3	$395K	Buy	+12,767	New	+$424K	0.01%	650
2013 Q4	–	Sell	-14,170	Closed	-$294K	–	1177
2013 Q3	$294K	Buy	+14,170	New	+$344K	0.01%	796

Other funds holding OFIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Stevens Capital Management's OFIX Position: Q4 2017 in Review

Stevens Capital Management sold out of Orthofix Medical (OFIX) in Q4 2017, closing a stake of 9,038 shares — an estimated $427K sold.

Stevens Capital Management first reported a position in OFIX in Q3 2013 and held it in 13 quarters. The position peaked at $529K in Q1 2017. 164 funds tracked by Wall St. Rank hold OFIX as of Q4 2017.

Stevens Capital Management reported no remaining Orthofix Medical position as of Q4 2017 after selling out during the quarter.
Stevens Capital Management sold 9,038 Orthofix Medical shares in Q4 2017, an estimated $427K.
Stevens Capital Management first reported a position in Orthofix Medical in Q3 2013 and held it in 13 quarters.
Stevens Capital Management's Orthofix Medical position peaked at $529K in Q1 2017.
164 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2017.

Based on Stevens Capital Management's 13F filing for Q4 2017, filed 13 Feb 2018.